| |
 |
|
Class Information
Number: 435/372.3
Name: Chemistry: molecular biology and microbiology > Animal cell, per se (e.g., cell lines, etc.); composition thereof; process of propagating, maintaining or preserving an animal cell or composition thereof; process of isolating or separating an animal cell or composition thereof; process of preparing a composition containing an animal cell; culture media therefore > Primate cell, per se > Human > Blood, lymphatic, or bone marrow origin or derivative > T-cell or derivative
Description: Subject matter wherein the human cell is a T-cell; i.e., T-lymphocyte.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 8709710 |
Methods of modulating interleukin-22 and immune response by notch regulators |
Apr. 29, 2014 |
| 8691572 |
Diagnosing, monitoring and treating inflammation |
Apr. 8, 2014 |
| 8679841 |
Allogeneic cell compositions with cross-linked CD3/CD28 |
Mar. 25, 2014 |
| 8658178 |
Carbon nanotube compositions and methods of use thereof |
Feb. 25, 2014 |
| 8658159 |
Method to induce and expand therapeutic alloantigen-specific human regulatory T cells in large-scale |
Feb. 25, 2014 |
| 8637307 |
Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool |
Jan. 28, 2014 |
| 8617884 |
Methods for eliminating at least a substantial portion of a clonal antigen-specific memory T cell subpopulation |
Dec. 31, 2013 |
| 8603815 |
CD4.sup.+ CD25.sup.- T cells and Tr1-like regulatory T cells |
Dec. 10, 2013 |
| 8603814 |
Method of inhibiting nonsense-mediated mRNA decay |
Dec. 10, 2013 |
| 8591956 |
Method of increasing immunological effect |
Nov. 26, 2013 |
| 8586359 |
Compositions and methods of preparing alloreactive cytotoxic T cells |
Nov. 19, 2013 |
| 8568994 |
Method for prenatal diagnosis |
Oct. 29, 2013 |
| 8563308 |
Culture-expanded T suppressor cells and methods of use thereof |
Oct. 22, 2013 |
| 8562974 |
Method for expanding Cd4+ Cd25+ T regulator cells |
Oct. 22, 2013 |
| 8557533 |
Screening method for the identification of agents capable of activating CD4+CD25+ regulatory T-cells through interactions with the HIV-1 GP120 binding site on CD4 |
Oct. 15, 2013 |
| 8546137 |
Inhibition of dendritic cell-driven regulatory T cell activation and potentiation of tumor antigen-specific T cell responses by interleukin-15 and MAP kinase inhibitor |
Oct. 1, 2013 |
| 8530187 |
Methods for transfecting natural killer cells |
Sep. 10, 2013 |
| 8524505 |
Blood analyzer and blood analyzing method |
Sep. 3, 2013 |
| 8513010 |
Dendritic cells pulsed with a bisphosphonate |
Aug. 20, 2013 |
| 8497118 |
Chimeric immunoreceptor useful in treating human cancers |
Jul. 30, 2013 |
| 8492146 |
Process for producing a human T-cell population having both cytotoxic and immunosuppressive activities |
Jul. 23, 2013 |
| 8383401 |
T-cell receptor and nucleic acid encoding the receptor |
Feb. 26, 2013 |
| 8383099 |
Adoptive cell therapy with young T cells |
Feb. 26, 2013 |
| 8361794 |
Cells expressing a modified T cell receptor |
Jan. 29, 2013 |
| 8354276 |
T-cell compositions that elicit type I cytokine response |
Jan. 15, 2013 |
| 8349810 |
Methods for targeted cleavage and recombination of CCR5 |
Jan. 8, 2013 |
| 8338173 |
Preparation of antigen-presenting human .gamma..delta. T cells and use in immunotherapy |
Dec. 25, 2012 |
| 8324353 |
Chimeric immunoreceptor useful in treating human gliomas |
Dec. 4, 2012 |
| 8323969 |
Preparation of regulatory T cells using ICAM-1 co-stimulation |
Dec. 4, 2012 |
| 8313944 |
Methods to cause differentiation of T-cells for use in cell therapy |
Nov. 20, 2012 |
| 8287857 |
Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy |
Oct. 16, 2012 |
| 8241621 |
Stem cell mediated treg activation/expansion for therapeutic immune modulation |
Aug. 14, 2012 |
| 8216837 |
Method of producing lymphocytes |
Jul. 10, 2012 |
| 8153426 |
Preparation of antigen-presenting human gamma-delta T cells and use in immunotherapy |
Apr. 10, 2012 |
| 8133728 |
Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
Mar. 13, 2012 |
| 8129185 |
Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses |
Mar. 6, 2012 |
| 8124069 |
Immunogenic peptides |
Feb. 28, 2012 |
| 8124408 |
Preparation of inactivated artificial antigen presenting cells and their use in cell therapies |
Feb. 28, 2012 |
| 8119401 |
IL-10 gene transfer to peripheral mononuclear cells |
Feb. 21, 2012 |
| 8080416 |
Method for determining the immunogenicity of an antigen |
Dec. 20, 2011 |
| 8076134 |
CD4+CD25- T cells and Tr1-like regulatory T cells |
Dec. 13, 2011 |
| 8076133 |
Method for obtaining antigen-specific Tr1 regulatory lymphocytes |
Dec. 13, 2011 |
| 8076135 |
Method of preparing a treatment effective amount of allogeneic T-cells |
Dec. 13, 2011 |
| 8071373 |
Co-culture lymphoid tissue equivalent (LTE) for an artificial immune system (AIS) |
Dec. 6, 2011 |
| 8071374 |
Methods for preparing T-cells for cell therapy |
Dec. 6, 2011 |
| 8053235 |
Methods of generating antigen-specific CD4+CD25+regulatory T cells, compositions and methods of use |
Nov. 8, 2011 |
| 8034334 |
Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy |
Oct. 11, 2011 |
| 8017110 |
Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light |
Sep. 13, 2011 |
| 8017730 |
T cell receptors which specifically bind to VYGFVRACL-HLA-A24 |
Sep. 13, 2011 |
| 8012470 |
Method for ex vivo immunization using heterologous intact bispecific and/or trispecific antibodies |
Sep. 6, 2011 |
|
|
|
